- Bruker (BRKR, Financial) anticipates Q1 2025 revenue between $795 million to $800 million, surpassing company and consensus expectations.
- The company reported approximately 10% year-over-year revenue growth with low-double digit growth at constant exchange rates.
- Complete financial results and an earnings call are scheduled for May 7, 2025.
Bruker Corporation (BRKR) has announced its preliminary revenue figures for the first quarter of 2025, projecting revenue to be in the range of $795 million to $800 million. This outlook exceeds the company's preliminary guidance and market consensus, showcasing an approximately 10% increase in revenue compared to the same period last year. This growth is further emphasized by a low-double digit percentage increase when adjusted for constant exchange rates.
The Bruker Scientific Instrument (BSI) segment reported mid-single digit percentage organic revenue growth, highlighting strong performance and demand in sectors such as biopharma and academic research. However, the BEST segment experienced a high-teens percentage decline in organic revenue, signaling challenges within its superconductors and magnet technology division.
Bruker plans to release its full Q1 2025 financial results on May 7, 2025, prior to the market opening. An earnings conference call and webcast are also scheduled for 8:30 a.m. Eastern Daylight Time on the same day, which will provide further detail on the company's financial performance and business developments.
